Cloud-clone
SKU(재고 관리 코드):PAA006Mu01
Polyclonal Antibody to Amphiregulin (AREG)
Polyclonal Antibody to Amphiregulin (AREG)
Immunohistochemistry: 5-20µg/mL;1:30-120
Immunocytochemistry: 5-20µg/mL;1:30-120
Optimal working dilutions must be determined by end user.
Product No.
PAA006Mu01
Organism Species
Mus musculus (Mouse).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPA006Mu01-Recombinant Amphiregulin (AREG)
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
0.63mg/ml
Organism Species More
n/a
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against AREG. It has been selected for its ability to recognize AREG in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-2µg/mL;1:300-1200
Immunohistochemistry: 5-20µg/mL;1:30-120
Immunocytochemistry: 5-20µg/mL;1:30-120
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Onkologie | Amphiregulin and Epiregulin Expression in Colorectal Carcinoma and the Correlation with Clinicopathological Characteristics Karger: 315380 |
| Br J Cancer. | Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer. Pubmed:24800946 |
| Cancer Sci | Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer PubMed: 25707609 |
| J Cancer Res Clin Oncol | Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer PubMed: 26195282 |
| Oncotarget. | Serum level of hepatocyte growth factor is a novel marker of predicting theoutcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer Pubmed:26716644 |
| Acta Pharmacologica Sinica | Anti-asthmatic activity of alkaloid compounds from Pericarpium Citri Reticulatae (Citrus reticulata 'Chachi') Pubmed: 19363516 |
| International Journal of Biological Sciences | CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17 |
| Neoplasia | Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine Pubmed: 33212364 |
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | Polarization of ADAM17‐driven EGFR signalling in electric field‐guided collective migration of epidermal sheets Pubmed: 33164313 |
| Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA006Mu02 | Recombinant Amphiregulin (AREG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA006Mu01 | Recombinant Amphiregulin (AREG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA006Mu01 | Polyclonal Antibody to Amphiregulin (AREG) | WB; IHC; ICC; IP. |
| PAA006Mu02 | Polyclonal Antibody to Amphiregulin (AREG) | WB; IHC; ICC; IP. |
| SEA006Mu | ELISA Kit for Amphiregulin (AREG) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA006Mu | CLIA Kit for Amphiregulin (AREG) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA006Mu | Magnetic Luminex Assay Kit for Amphiregulin (AREG) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
